Login
$ENOV
$27.92 +$0.00 (0.0%) After hours

$ENOV SEC Filings

Filed On Filing
16 Nov 2026 Form 4: Lalor Angela S, Director

Bought 874 shares ($24.5K) · Bought 880 shares ($24.9K)

16 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 Form 4: Wienbar Sharon L, Director

Bought 874 shares ($24.8K) · Bought 900 shares ($25K)

12 Nov 2026 Form 4: Lalor Angela S, Director

Bought 887 shares ($25.1K) · Bought 870 shares ($25.1K)

10 Nov 2026 Form 4: Wienbar Sharon L, Director

Bought 907 shares ($25K) · Bought 924 shares ($24.9K)

05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

Dallas, TX, November 5, 2026 (GLOBE NEWSWIRE)—Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the third quarter ended October...

01 Oct 2026 Form 4: Ortiz Christine, Director

Received 958 shares as a grant or award

08 Sep 2026 Form 4: Engert Oliver, Chief Administrative Officer

Bought 2,660 shares ($50K)

04 Sep 2026 Form 4: Engert Oliver, Chief Administrative Officer

Bought 2,458 shares ($49.9K) · Bought 5,140 shares ($100K)

04 Sep 2026 Form 4: McDonald Damien, Director

Bought 13,035 shares ($250K)

01 Sep 2026 8-K: Regulation FD Disclosure

Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics

14 Aug 2026 SCHEDULE 13G
06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition

Dallas, TX, August 6, 2026 (GLOBE NEWSWIRE)—Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the second quarter ended July 3, ...

28 Jul 2026 SCHEDULE 13G/A
08 Jul 2026 SCHEDULE 13G/A
01 Jul 2026 Form 4: Ortiz Christine, Director

Received 846 shares as a grant or award

26 Jun 2026 11-K
16 Jun 2026 Form 4: Engert Oliver, Chief Administrative Officer

Bought 1,000 shares ($20.9K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support